Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Home-Based Kidney Care, Patient Activation, and Risk Factors for CKD Progression in Zuni Indians: A Randomized, Controlled Clinical Trial.

Nelson RG, Pankratz VS, Ghahate DM, Bobelu J, Faber T, Shah VO.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1801-1809. doi: 10.2215/CJN.06910618. Epub 2018 Nov 15.

PMID:
30442864
2.

Impact of Isolyte Versus 0.9% Saline on Postoperative Event of Acute Kidney Injury Assayed by Urinary [TIMP-2] × [IGFBP7] in Patients Undergoing Cardiac Surgery.

Lee NM, Deriy L, Petersen TR, Shah VO, Hutchens MP, Gerstein NS.

J Cardiothorac Vasc Anesth. 2019 Feb;33(2):348-356. doi: 10.1053/j.jvca.2018.07.042. Epub 2018 Aug 1.

PMID:
30181085
3.

The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds.

Armamento-Villareal R, Shah VO, Aguirre LE, Meisner AL, Qualls C, Royce ME.

Front Genet. 2016 Dec 2;7:211. eCollection 2016.

4.

PERFORMANCE OF A1C VERSUS OGTT FOR THE DIAGNOSIS OF PREDIABETES IN A COMMUNITY-BASED SCREENING.

Camacho JE, Shah VO, Schrader R, Wong CS, Burge MR.

Endocr Pract. 2016 Nov;22(11):1288-1295. Epub 2016 Aug 2.

5.

Patient and Other Stakeholder Engagement in Patient-Centered Outcomes Research Institute Funded Studies of Patients with Kidney Diseases.

Cukor D, Cohen LM, Cope EL, Ghahramani N, Hedayati SS, Hynes DM, Shah VO, Tentori F, Unruh M, Bobelu J, Cohen S, Dember LM, Faber T, Fischer MJ, Gallardo R, Germain MJ, Ghahate D, Grote N, Hartwell L, Heagerty P, Kimmel PL, Kutner N, Lawson S, Marr L, Nelson RG, Porter AC, Sandy P, Struminger BB, Subramanian L, Weisbord S, Young B, Mehrotra R.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1703-12. doi: 10.2215/CJN.09780915. Epub 2016 May 19. Review.

6.

Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND).

Williams RC, Elston RC, Kumar P, Knowler WC, Abboud HE, Adler S, Bowden DW, Divers J, Freedman BI, Igo RP Jr, Ipp E, Iyengar SK, Kimmel PL, Klag MJ, Kohn O, Langefeld CD, Leehey DJ, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Rotter JI, Schelling JR, Sedor JR, Shah VO, Smith MW, Taylor KD, Thameem F, Thornley-Brown D, Winkler CA, Guo X, Zager P, Hanson RL; FIND Research Group.

BMC Genomics. 2016 May 4;17:325. doi: 10.1186/s12864-016-2654-x.

7.

Composition, Diversity and Abundance of Gut Microbiome in Prediabetes and Type 2 Diabetes.

Lambeth SM, Carson T, Lowe J, Ramaraj T, Leff JW, Luo L, Bell CJ, Shah VO.

J Diabetes Obes. 2015 Dec 26;2(3):1-7.

8.

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).

Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW, Burlock A, Chen YD, Cole SA, Comeau ME, Curtis JM, Divers J, Drechsler C, Duggirala R, Elston RC, Guo X, Huang H, Hoffmann MM, Howard BV, Ipp E, Kimmel PL, Klag MJ, Knowler WC, Kohn OF, Leak TS, Leehey DJ, Li M, Malhotra A, März W, Nair V, Nelson RG, Nicholas SB, O'Brien SJ, Pahl MV, Parekh RS, Pezzolesi MG, Rasooly RS, Rotimi CN, Rotter JI, Schelling JR, Seldin MF, Shah VO, Smiles AM, Smith MW, Taylor KD, Thameem F, Thornley-Brown DP, Truitt BJ, Wanner C, Weil EJ, Winkler CA, Zager PG, Igo RP Jr, Hanson RL, Langefeld CD; Family Investigation of Nephropathy and Diabetes (FIND).

PLoS Genet. 2015 Aug 25;11(8):e1005352. doi: 10.1371/journal.pgen.1005352. eCollection 2015 Aug.

9.

Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.

VanderJagt TA, Neugebauer MH, Morgan M, Bowden DW, Shah VO.

World J Diabetes. 2015 Aug 10;6(9):1113-21. doi: 10.4239/wjd.v6.i9.1113.

10.

A Home-Based Educational Intervention Improves Patient Activation Measures and Diabetes Health Indicators among Zuni Indians.

Shah VO, Carroll C, Mals R, Ghahate D, Bobelu J, Sandy P, Colleran K, Schrader R, Faber T, Burge MR.

PLoS One. 2015 May 8;10(5):e0125820. doi: 10.1371/journal.pone.0125820. eCollection 2015. Review.

11.

Genetics of kidney disease and related cardiometabolic phenotypes in Zuni Indians: the Zuni Kidney Project.

Laston SL, Voruganti VS, Haack K, Shah VO, Bobelu A, Bobelu J, Ghahate D, Harford AM, Paine SS, Tentori F, Cole SA, MacCluer JW, Comuzzie AG, Zager PG.

Front Genet. 2015 Jan 30;6:6. doi: 10.3389/fgene.2015.00006. eCollection 2015.

12.

NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population.

Garner CJ, Conn CA, Cohen D, Luo L, Castillo JJ, Shah VO, Garver WS.

J Diabetes Obes. 2015;2(2). doi: 10.15436/2376-0494.15.024. Epub 2015 Jul 27.

13.

Assessing knowledge and attitudes of diabetes in Zuni Indians using a culture-centered approach.

Newman S, Cheng T, Ghahate DM, Bobelu J, Sandy P, Faber T, Shah VO.

PLoS One. 2014 Jun 11;9(6):e99614. doi: 10.1371/journal.pone.0099614. eCollection 2014.

14.

Identifying barriers to healthcare to reduce health disparity in Zuni Indians using focus group conducted by community health workers.

Shah VO, Ghahate DM, Bobelu J, Sandy P, Newman S, Helitzer DL, Faber T, Zager P.

Clin Transl Sci. 2014 Feb;7(1):6-11. doi: 10.1111/cts.12127. Epub 2013 Nov 8.

15.

A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).

Thameem F, Igo RP Jr, Freedman BI, Langefeld C, Hanson RL, Schelling JR, Elston RC, Duggirala R, Nicholas SB, Goddard KA, Divers J, Guo X, Ipp E, Kimmel PL, Meoni LA, Shah VO, Smith MW, Winkler CA, Zager PG, Knowler WC, Nelson RG, Pahl MV, Parekh RS, Kao WH, Rasooly RS, Adler SG, Abboud HE, Iyengar SK, Sedor JR; Family Investigation of Nephropathy and Diabetes Research Group.

PLoS One. 2013 Dec 17;8(12):e81888. doi: 10.1371/journal.pone.0081888. eCollection 2013.

16.

Plasma metabolomic profiles in different stages of CKD.

Shah VO, Townsend RR, Feldman HI, Pappan KL, Kensicki E, Vander Jagt DL.

Clin J Am Soc Nephrol. 2013 Mar;8(3):363-70. doi: 10.2215/CJN.05540512. Epub 2012 Dec 6.

17.

Comparison of the fatty acid composition of the serum phospholipids of controls, prediabetics and adults with type 2 diabetes.

Chuang LT, Glew RH, Li CC, VanderJagt DJ, Broyles JS, Ray GM, Shah VO.

J Diabetes Mellitus. 2012 Nov;2(4):393-401.

18.

Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2012 Dec;7(12):1938-46. doi: 10.2215/CJN.03500412. Epub 2012 Sep 27.

19.

Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects.

Wilmot B, Voruganti VS, Chang YP, Fu Y, Chen Z, Taylor HA, Wilson JG, Gipson T, Shah VO, Umans JG, Flessner MF, Hitzemann R, Shuldiner AR, Comuzzie AG, McWeeney S, Zager PG, Maccluer JW, Cole SA, Cohen DM.

Physiol Genomics. 2012 Feb 13;44(3):220-8. doi: 10.1152/physiolgenomics.00153.2011. Epub 2011 Dec 20.

20.

Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study.

Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, Hanson RL, Duggirala R, Divers J, Abboud H, Adler SG, Arar NH, Horvath A, Elston RC, Bowden DW, Guo X, Ipp E, Kao WH, Kimmel PL, Knowler WC, Meoni LA, Molineros J, Nelson RG, Pahl MV, Parekh RS, Rasooly RS, Schelling JR, Shah VO, Smith MW, Winkler CA, Zager PG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes Research Group.

Am J Nephrol. 2011;33(5):381-9. doi: 10.1159/000326763. Epub 2011 Mar 31.

21.

Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.

MacCluer JW, Scavini M, Shah VO, Cole SA, Laston SL, Voruganti VS, Paine SS, Eaton AJ, Comuzzie AG, Tentori F, Pathak DR, Bobelu A, Bobelu J, Ghahate D, Waikaniwa M, Zager PG.

Am J Kidney Dis. 2010 Aug;56(2):289-302. doi: 10.1053/j.ajkd.2010.03.012. Epub 2010 Jun 19.

22.

Natural products inhibit LPS-induced activation of pro-inflammatory cytokines in peripheral blood mononuclear cells.

Shah VO, Ferguson JE, Hunsaker LA, Deck LM, Vander Jagt DL.

Nat Prod Res. 2010 Jul;24(12):1177-88. doi: 10.1080/14786410903112680.

PMID:
20582811
23.

Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group.

Malhotra A, Igo RP Jr, Thameem F, Kao WH, Abboud HE, Adler SG, Arar NH, Bowden DW, Duggirala R, Freedman BI, Goddard KA, Ipp E, Iyengar SK, Kimmel PL, Knowler WC, Kohn O, Leehey D, Meoni LA, Nelson RG, Nicholas SB, Parekh RS, Rich SS, Chen YD, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Taylor KD, Thornley-Brown D, Zager PG, Horvath A, Hanson RL; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes Metab Res Rev. 2009 Nov;25(8):740-7. doi: 10.1002/dmrr.1031.

24.

Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.

Raj DS, Carrero JJ, Shah VO, Qureshi AR, Bárány P, Heimbürger O, Lindholm B, Ferguson J, Moseley PL, Stenvinkel P.

Am J Kidney Dis. 2009 Dec;54(6):1072-80. doi: 10.1053/j.ajkd.2009.06.022. Epub 2009 Sep 6.

25.

Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis.

Raj DS, Shah VO, Rambod M, Kovesdy CP, Kalantar-Zadeh K.

Am J Kidney Dis. 2009 Dec;54(6):1062-71. doi: 10.1053/j.ajkd.2009.06.028. Epub 2009 Aug 20.

26.

Mitochondrial DNA deletion and sarcopenia.

Shah VO, Scariano J, Waters D, Qualls C, Morgan M, Pickett G, Gasparovic C, Dokladny K, Moseley P, Raj DS.

Genet Med. 2009 Mar;11(3):147-52. doi: 10.1097/GIM.0b013e31819307a2.

27.

Heritability of the severity of diabetic retinopathy: the FIND-Eye study.

Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, Guo X, Hanson RL, Igo RP Jr, Ipp E, Kimmel PL, Knowler WC, Molineros J, Nelson RG, Pahl MV, Quade SR, Rasooly RS, Rotter JI, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Zager PG, Abboud HE; Family Investigation of Nephropathy and Diabetes Research Group.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3839-45. doi: 10.1167/iovs.07-1633.

28.

Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.

Degaffe GH, Vander Jagt DL, Bobelu A, Bobelu J, Neha D, Waikaniwa M, Zager P, Shah VO.

J Diabetes Complications. 2008 Jul-Aug;22(4):267-72. doi: 10.1016/j.jdiacomp.2007.06.010. Epub 2008 Apr 16.

29.

Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis.

Raj DS, Moseley P, Dominic EA, Onime A, Tzamaloukas AH, Boyd A, Shah VO, Glew R, Wolfe R, Ferrando A.

Kidney Int. 2008 May;73(9):1054-61. doi: 10.1038/ki.2008.21. Epub 2008 Feb 20.

30.

Haemodialysis induces mitochondrial dysfunction and apoptosis.

Raj DS, Boivin MA, Dominic EA, Boyd A, Roy PK, Rihani T, Tzamaloukas AH, Shah VO, Moseley P.

Eur J Clin Invest. 2007 Dec;37(12):971-7.

PMID:
18036031
31.

Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND).

Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Saad MF, Scavini M, Smith MW, Taylor K, Winkler CA, Zager PG, Shah VO; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes. 2008 Jan;57(1):235-43. Epub 2007 Nov 14.

32.

The burden of chronic kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Stidley CA, Paine SS, Shah VO, Tentori F, Bobelu A, Welty TK, MacCluer JW, Zager PG.

Clin J Am Soc Nephrol. 2007 May;2(3):509-16. Epub 2007 Apr 18.

33.

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).

Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Sedor JR, Sehgal AR, Shah VO, Smith MW, Taylor KD, Winkler CA, Zager PG, Freedman BI; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes. 2007 Jun;56(6):1577-85. Epub 2007 Mar 15.

34.

Hemodialysis modulates gene expression profile in skeletal muscle.

Shah VO, Dominic EA, Moseley P, Pickett G, Fleet M, Ness S, Raj DS.

Am J Kidney Dis. 2006 Oct;48(4):616-28.

PMID:
16997058
35.

Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease.

Raj DS, Dominic EA, Pai A, Osman F, Morgan M, Pickett G, Shah VO, Ferrando A, Moseley P.

Kidney Int. 2005 Nov;68(5):2338-44.

36.

Kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Shah VO, Stidley CA, Tentori F, Paine SS, Harford AM, Narva AS, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Welty TK, MacCluer JW, Zager PG.

Kidney Int Suppl. 2005 Aug;(97):S126-31.

37.

Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines.

Raj DS, Dominic EA, Wolfe R, Shah VO, Bankhurst A, Zager PG, Ferrando A.

Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E658-64. Epub 2004 Jan 13.

38.

Markers of inflammation, proteolysis, and apoptosis in ESRD.

Raj DS, Shah H, Shah VO, Ferrando A, Bankhurst A, Wolfe R, Zager PG.

Am J Kidney Dis. 2003 Dec;42(6):1212-20.

PMID:
14655193
39.

Protein turnover and amino acid transport kinetics in end-stage renal disease.

Raj DS, Zager P, Shah VO, Dominic EA, Adeniyi O, Blandon P, Wolfe R, Ferrando A.

Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E136-43. Epub 2003 Sep 16.

40.

The Zuni kidney project: a collaborative approach to an epidemic of kidney disease.

Stidley CA, Shah VO, Scavini M, Narva AS, Kessler D, Bobelu A, MacCluer JW, Welty TK, Zager PG.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S139-43.

41.

Acute tubular injury causes dysregulation of cellular cholesterol transport proteins.

Zager RA, Johnson AC, Hanson SY, Shah VO.

Am J Pathol. 2003 Jul;163(1):313-20.

42.

Prevalence of hematuria among Zuni Indians with and without diabetes: The Zuni kidney Project.

Tentori F, Stidley CA, Scavini M, Shah VO, Narva AS, Paine S, Bobelu A, Welty TK, Maccluer JW, Zager PG.

Am J Kidney Dis. 2003 Jun;41(6):1195-204.

PMID:
12776271
43.

Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project.

Shah VO, Scavini M, Stidley CA, Tentori F, Welty TK, MacCluer JW, Narva AS, Bobelu A, Albert CP, Kessler DS, Harford AM, Wong CS, Harris AA, Paine S, Zager PG.

J Am Soc Nephrol. 2003 May;14(5):1320-9.

44.

Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.

Johnson AC, Yabu JM, Hanson S, Shah VO, Zager RA.

Am J Pathol. 2003 Jan;162(1):283-91.

45.

Prevalence of diabetes is higher among female than male Zuni indians.

Scavini M, Stidley CA, Shah VO, Narva AS, Tentori F, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Waikaniwa M, Welty TK, MacCluer JW, Zager PG.

Diabetes Care. 2003 Jan;26(1):55-60.

PMID:
12502658
46.

The mevalonate pathway during acute tubular injury: selected determinants and consequences.

Zager RA, Shah VO, Shah HV, Zager PG, Johnson AC, Hanson S.

Am J Pathol. 2002 Aug;161(2):681-92.

47.

A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease.

Stidley CA, Shah VO, Narva AS, Dalton D, MacCluer JW, Bobelu A, Scavini M, Welty TK, Zager PG.

Am J Kidney Dis. 2002 Feb;39(2):358-68.

PMID:
11840378
48.

Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy.

Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG.

J Clin Endocrinol Metab. 1998 Aug;83(8):2886-91.

PMID:
9709964
49.

A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes.

Eaton RP, Sibbitt WL Jr, Shah VO, Dorin RI, Zager PG, Bicknell JM.

J Diabetes Complications. 1998 Jan-Feb;12(1):34-8.

PMID:
9442813
50.

Aldose reductase gene expression is increased in diabetic nephropathy.

Shah VO, Dorin RI, Sun Y, Braun M, Zager PG.

J Clin Endocrinol Metab. 1997 Jul;82(7):2294-8.

PMID:
9215310

Supplemental Content

Support Center